Letters
New UK antimicrobial resistance strategy
UK antimicrobial resistance strategy must be set in a wider context
BMJ 2013; 346 doi: https://doi.org/10.1136/bmj.f2999 (Published 15 May 2013) Cite this as: BMJ 2013;346:f2999
- Peter M Hawkey, professor of clinical and public health bacteriology1,
- Bharat C Patel, consultant medical microbiologist2,
- Alexander J Trees, peer3
- 1Institute of Microbiology and Infection, University of Birmingham, Birmingham B15 2TT, UK
- 2Public Health Laboratory London, Public Health England, Barts Healthcare NHS Trust, Division of Infection, London, UK
- 3House of Lords, London, UK
- peter.hawkey{at}heartofengland.nhs.uk
We welcome the editorial on the chief medical officer’s intent to tackle the rise of antimicrobial resistance.1 The remarkable success in reducing meticillin resistant Staphylococcus aureus bacteraemia to less than 2% exposes the rapidly growing problem of bacteraemia caused by Gram negative bacteria, particularly Escherichia coli (36%).2 E coli differs from most agents …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £184 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£50 / $60/ €56 (excludes VAT)
You can download a PDF version for your personal record.